Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. (Q52242595)
scientific article published in May 1998
Language:
(P31) (Q13442814)
(P304) 1101-1109
(P407) (Q1860)
(P433) 5
(P478) 4
(P577) Friday, May 1, 1998
(P1433) (Q332253)
(P1476) "Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies." (language: en)
(P2093) Nemunaitis J
Poole C
Primrose J
Rosemurgy A
Malfetano J
Brown P
Berrington A
Cornish A
Lynch K
Rasmussen H
Kerr D
Cox D
Millar A
other details
description scientific article published in May 1998

External Links